Please login to the form below

Not currently logged in
Email:
Password:

EB-101

This page shows the latest EB-101 news and features for those working in and with pharma, biotech and healthcare.

Abeona Therapeutics’ rare disease phase 3 trial halted due to FDA concerns

Abeona Therapeutics’ rare disease phase 3 trial halted due to FDA concerns

Issues over transport stability must be resolved, says regulator. The FDA has put Abeona Therapeutics’ phase 3 trial of its cell therapy EB-101 on hold, asking for “additional data” to ... Abeona recently reported that EB-101 induced sustained

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Redbow Consulting Group

Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....